Doctors and researchers at the Texas Heart Institute (THI) are halfway to their goal of recruiting 80 patients who suffer from peripheral artery disease (PAD) for a new clinical trial to assess the benefits and risks in the use of adult stem cells from patients’ own bone marrow to treat leg pain commonly associated with the disease.
PAD affects between 8 million and 10 million Americans. The primary leg symptom is called “intermittent claudication”, which can manifest as aching, cramps, numbness or feeling of fatigue in the leg muscles. These symptoms occur in approximately 1 million to 3 million sufferers of the disease.
Many with PAD may not be able to enjoy a relief of these leg symptoms with any of the currently available therapies, which range from exercise to medications to endovascular and open surgical options. Current treatments are associated with risk, may not provide longstanding symptom relief, and/or may not be cost-effective.
“Cell therapy has been studied in patients with heart disease and severe PAD,” said Dr. Emerson Perin, Director of THI’s Stem Cell Center, “But, it has not been adequately evaluated in individuals with intermittent claudication. We are hoping to change that.”
Researchers are excited to announce that the study is halfway toward its goal of recruiting 80 patients. The Stem Cell Center continues to work and is actively seeking referrals from the surrounding healthcare community. The goal is to complete enrollment in this trial by the end of 2015.
“It is important that patients who think they might be eligible and physicians with patients who may benefit from the study contact us soon” said Dr. Perin.
The PACE trial (Patients with Intermittent Claudication Injected with ALDH Bright Cells), is being conducted under the auspices of the Cardiovascular Cell Therapy Network (CCTRN), a network of cell research centers, including THI, sponsored by the National Heart Lung and Blood Institute (NHLBI).
PACE is a randomized clinical trial that will evaluate leg blood flow and symptoms in two groups of patients: a) those treated with their own adult stem cells, and b) those treated with placebo. All patients will be followed for one year.
The treatment group will receive ALDH Bright Cells (ALD-301), which are pluripotent (develop into many cell types) stem cells isolated from the patients’ own bone marrow (autologous) through a proprietary Cytomedix technology. Preclinical research suggests that ALDH Bright Cells may promote the repair of tissue damage caused by inadequate blood supply (ischemia) and restore blood flow through cell recruitment and angiogenesis (the formation of new blood vessels). Cytomedix is an industry partner with CCTRN for the PACE trial.
PACE also includes an important new scientific component to determine whether state-of-the-art imaging can predict clinical improvement. “It is our hope that state-of-the-art imaging assessments will be sensitive detectors of the injected cells’ effects,” added Dr. Lem Moyé, principal investigator at the CCTRN Data Coordinating Center at the University of Texas School of Public Health in Houston.
RT @McGovernMed: Register now for the Pediatric Neuroscience Symposium at Children's Memorial Hermann Hospital on Saturday, May 4! #McGover…
CHI St. Luke's Health@CHI_StLukes
Our love for #GreaterHouston is at the heart of everything we do. In our mission to create healthier communities, we’re sharing our favorite places to inspire health and happiness in our neighbors: https://t.co/oegrvNAWh9 #WeHeartHouston https://t.co/lO6veLnoku
The mystery of ‘mylk’ drove this Rice alumna coco-nuts! Luckily, a group of freshmen helped this entrepreneur find the right mix for shelf-stable vegan coconut milk. https://t.co/cYPiZxKVqT https://t.co/uIvYfwFJYA
RT @BCMCancerCenter: Did you know you can still sign up for tomorrow's Lunch and Learn with Dr. Andrew Sikora hosted by @TheWomensFund? Be…
In honor of National Autism Awareness Month, Dr. Ruth Ann Luna shares the side of autism you don't see often: https://t.co/UuGS12BGqJ #texaschildrens
Harris Health System@harrishealth
Going through menopause can be a bit like traveling in a new city without a map—or even a clear destination. In fact, you may not even realize you’re there until you’ve passed it. Here's how to better cope with this midlife milestone. https://t.co/6s25Aji4oe https://t.co/YUNpLFz3hh
.@VANatCemeteries Veteran sees duty at 35 locations https://t.co/aFx133klvV #VAntagePoint
Let’s bring to light some surprising habits that could be damaging your skin: https://t.co/7VXEaHA9CT. https://t.co/dioqIgDfHD
Vitiligo, Alopecia Merely Cosmetic? Think Again https://t.co/IrsX5jsoMq
MD Anderson Cancer Center@MDAndersonNews
You don’t need any equipment to do #strengthtraining. Here are our tips for an at-home workout: https://t.co/B6LU00kIH9 @FocusedonHealth #endcancer https://t.co/fjCJ2TuPz5
Running and enjoying treats in moderation are just some of the ways Dr. Christina Weng stays fit. See more of her healthy habits: https://t.co/ttuEhmpRmU #healthy #habits https://t.co/NNehV0jfJD
Join us for season two of @TexasChildrens podcast series, Outcomes! Every day incredible stories occur inside our walls, here are a few of those such stories.--> https://t.co/73SXLUB5Pv (Don't forget to subscribe!) https://t.co/fA7C3hgMgJ
RT @SecWilkie: I had the opportunity to share my command philosophy “Walk the Post" at VHA’s NLC meeting earlier today. I am honored to b…
This could be why your hands are always so cold: https://t.co/T6p3d32EZS
RT @isiahcareyFOX26: Amazing story by the staff at TMC News and edited by our good friend @CindyGeorge https://t.co/KHcTqCVp1h!